Illumina DNA Test Tech Accused of Infringing Hospital Patent (1)

Illumina Inc.'s genetic-sequencing software, used by clinical labs to rapidly identify disease-causing mutations, relies without permission on technology patented by the research arm of Nationwide Children’s Hospital Inc., a federal lawsuit said.

The Research Institute at Nationwide Children’s Hospital alleges Illumina’s DRAGEN Bio-IT software infringes US Patent No. 9,552,458, which covers methods to accelerate and improve genomic-data analysis, according to a complaint filed Tuesday in the US District Court for the District of Delaware. DRAGEN is an acronym for “Dynamic Read Analysis for GENomics.”

The suit seeks a court order blocking Illumina from making, using, selling, or importing the ...